Starting Your Weight Management Journey Safely
Wegovy vs Mounjaro Doses: Understanding Starter Requirements
When comparing Wegovy vs Mounjaro doses, the starting approach differs significantly between these two prescription-only medicines. Wegovy begins with a 0.25mg dose for weeks 1-4, designed to help your body gradually adjust to semaglutide's GLP-1 receptor agonist effects. This gentle introduction helps minimise potential side effects like nausea while your appetite regulation systems adapt. Mounjaro starts at 2.5mg of tirzepatide, reflecting its dual GIP and GLP-1 receptor mechanism that requires different dosing considerations.
The key difference in Wegovy vs Mounjaro doses lies in their escalation timelines and target mechanisms. Wegovy follows a structured 16-week escalation from 0.25mg to the maintenance dose of 2.4mg, with each dose level serving 4 weeks. Mounjaro uses 4-week intervals but targets different hormone pathways, requiring its own specific titration schedule. Both medicines must be prescribed alongside a reduced-calorie diet and increased physical activity, with dose escalation being mandatory for safety and effectiveness.
Wegovy Starter Dose Pricing and Value at EverydayMeds
Our Wegovy 0.25mg starter dose costs £79.99, representing the first step in your weight management journey. New customers can apply code FIRST40 at checkout, while returning customers use DOSE25 for the best available pricing. For those planning ahead, our Intro Duo bundle combines the 0.25mg starter with the 0.5mg second dose for £169.99, providing your first two months of treatment in one convenient order.
When evaluating Wegovy vs Mounjaro doses from a cost perspective, both require similar long-term investment patterns with different dose strengths and pricing structures. The Gentle Start Trio bundle offers 0.25mg, 0.25mg, and 0.5mg pens for £269.99, ideal if you need to take the initial dose more slowly under prescriber guidance. All pricing includes our clinical assessment, prescriber review by our GPhC-registered team (#9012878), and cold-chain delivery to maintain medication integrity.
Clinical Evidence Supporting Wegovy vs Mounjaro Dose Approaches
The STEP clinical trial programme established Wegovy's dose escalation schedule, with STEP 1 showing participants achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions. The careful dose titration from 0.25mg helps optimise both tolerability and effectiveness throughout the treatment period. Wilding et al., NEJM, 2021 demonstrated that this gradual approach supports sustained weight management outcomes.
Mounjaro's dose strategy reflects different clinical trial designs and its dual-hormone mechanism, making direct weight loss percentage comparisons inappropriate between the treatments. Both medicines have undergone rigorous testing, with their respective dose schedules designed to maximise benefits while minimising side effects. The choice between Wegovy vs Mounjaro doses should always be made with prescriber guidance based on individual medical history and treatment goals.
How Wegovy's Starting Dose Works in Your Body
Wegovy's 0.25mg starting dose introduces semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones. This medication works by slowing gastric emptying, promoting feelings of fullness after smaller meals, and may help reduce food cravings by acting on brain appetite centres. The starter dose allows your digestive system and appetite regulation mechanisms to adapt gradually, reducing the likelihood of significant gastrointestinal side effects. As you progress through the dose escalation schedule, the increasing semaglutide levels provide enhanced appetite suppression and satiety signals. The 0.25mg foundation dose establishes the treatment pathway that leads to the 2.4mg maintenance dose where optimal weight management effects are typically achieved.
EverydayMeds Ordering Process for Wegovy Starter Doses
Starting Wegovy through EverydayMeds begins with our 3-minute online clinical assessment, designed to capture essential medical history and weight management goals. Our GPhC-registered prescribers (#9012878) review your assessment within 3 working days, or 24 hours with our express service, ensuring thorough evaluation of your suitability for treatment. Once approved, your Wegovy 0.25mg starter dose ships via next-day delivery in temperature-controlled packaging to maintain medication integrity. Our clinical team remains available throughout your treatment journey to address questions about dose escalation and treatment progress. The entire process prioritises safety and convenience, allowing you to begin your weight management journey with professional oversight and ongoing support.
Storage and Practical Considerations for Wegovy vs Mounjaro Doses
Wegovy offers a significant practical advantage over Mounjaro regarding storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day limit. Both medicines require initial refrigerated storage at 2-8°C and use pre-filled injection pens, though Wegovy uses Novo Nordisk's FlexTouch pen system with proven reliability. The dose escalation schedule for Wegovy is clearly marked on each pen, with the 0.25mg starter dose delivered in a distinct pen to prevent confusion with higher strengths. Neither Wegovy nor Mounjaro doses can be split or combined, making the prescribed escalation schedule mandatory for both safety and treatment effectiveness. This storage advantage makes Wegovy particularly suitable for patients who travel frequently or prefer flexible medication management.
First-Month Expectations: Wegovy vs Mounjaro Starter Dose Experience
The first month on Wegovy's 0.25mg starter dose typically involves gradual appetite changes and potential mild gastrointestinal effects as your body adjusts to semaglutide. Most patients notice reduced hunger between meals and earlier satiety during eating, though weight loss in the first month is usually modest compared to later treatment stages. Managing initial side effects involves eating smaller portions, avoiding fatty foods, and staying well-hydrated throughout the dose adjustment period.
Comparing first-month experiences between Wegovy vs Mounjaro doses reveals different side effect profiles due to their distinct mechanisms, though both require similar lifestyle adjustments and medical monitoring. The 0.25mg Wegovy starter dose is specifically calibrated to minimise disruption while establishing treatment benefits, unlike higher starting doses that might cause more pronounced effects. Your prescriber can provide personalised guidance on managing the initial treatment phase and preparing for dose escalation to 0.5mg in week 5.
Professional Support and Treatment Optimisation
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment option aligns best with your medical profile and weight management objectives. Our clinical team understands the nuances of Wegovy vs Mounjaro doses, providing ongoing support as you progress through treatment phases. Starting with Wegovy's 0.25mg dose at £79.99 represents a commitment to medically supervised weight management, with clear escalation pathways and professional oversight. Remember to use code FIRST40 if you're a new customer, or DOSE25 for returning patients when placing your order at https://everydaymeds.co.uk/products/wegovy-0-25mg. The combination of clinical expertise, convenient access, and comprehensive treatment support ensures your weight management journey begins with the strongest possible foundation.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
